Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.
Journal: JCO precision oncology
Published: June 12, 2026
Enable CAR T cell immunotherapy in glioblastoma by modifying its microenvironment via oncolytic adenovirus encoding bispecific T cell engager.
Journal: Molecular therapy. Oncology
Published: January 12, 2026
Enabling CAR-T Cell Immunotherapy in Glioblastoma by Modifying Tumor Microenvironment via Oncolytic Adenovirus Encoding Bispecific T Cell Engager.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Corrigendum to Targeting apoptotic pathways for cancer therapy.
Journal: The Journal of clinical investigation
Published: July 15, 2025
Acquired resistance to molecularly targeted therapies for cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 25, 2024
Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.
Journal: ESMO open
Published: August 23, 2024
Targeting apoptotic pathways for cancer therapy.
Journal: The Journal of clinical investigation
Published: July 15, 2024
Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma.
Journal: bioRxiv : the preprint server for biology
Published: January 18, 2024
Nivolumab plus ONC201 plus in microsatellite stable (MSS) metastatic colorectal cancer (mCRC) patients: a Brown University Oncology Research Group phase Ib/II study (BrUOG379).
Journal: Translational gastroenterology and hepatology
Published: September 12, 2023
Last Updated: 09/26/2026